Paper · 1662630
An open study to compare the pharmacokinetics, safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers.
Coates P and 4 others. Eur J Clin Microbiol Infect Dis, 1991. Cited by 31 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. An open study to compare the pharmacokinetics, safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers. Papers, record 1662630. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1662630
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Erythromycin | Major topic |
| Administration, Oral | |
| Adolescent | |
| Adult | |
| Age Factors | |
| Aged | |
| Aged, 80 and over | |
| Azithromycin | |
| Drug Administration Schedule | |
| Drug Tolerance | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References5
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2,449,865 | Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/2449865 | PubMed |
| 2 | 2,154,442 | Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo. | J Antimicrob Chemother | 1990 | https://conductscience.org/library/papers/2154442 | PubMed |
| 3 | 1,244,564 | Prediction of creatinine clearance from serum creatinine. | Nephron | 1976 | https://conductscience.org/library/papers/1244564 | PubMed |
| 4 | 2,154,441 | The pharmacokinetics of azithromycin in human serum and tissues. | J Antimicrob Chemother | 1990 | https://conductscience.org/library/papers/2154441 | PubMed |
| 5 | 2,830,841 | Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/2830841 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,636,323 | Significant Predictors of Azithromycin in Population Pharmacokinetic Analysis: A Systematic Review. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40636323 | PubMed |
| 39,403,139 | An insight into pharmacokinetics and dose optimization of antimicrobials agents in elderly patients. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39403139 | PubMed |
| 28,429,305 | The Role of Macrolides in Chronic Rhinosinusitis (CRSsNP and CRSwNP). | Curr Allergy Asthma Rep | 2017 | https://conductscience.org/library/papers/28429305 | PubMed |
| 19,451,282 | Pharmacokinetics of EDP-420 after multiple oral doses in healthy adult volunteers and in a bioequivalence study. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19451282 | PubMed |
| 19,223,626 | Pharmacokinetics of EDP-420 after ascending single oral doses in healthy adult volunteers. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19223626 | PubMed |
| 8,913,468 | Safety, toleration, and pharmacokinetics of intravenous azithromycin. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8913468 | PubMed |
| 8,383,944 | Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8383944 | PubMed |
| 8,287,632 | Azithromycin clinical pharmacokinetics. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8287632 | PubMed |
| 7,840,560 | In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydia. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7840560 | PubMed |
| 7,486,938 | Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7486938 | PubMed |
1 to 10 of 11
See all 11 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1662630
GET https://conductscience.org/api/papers/v1/1662630/authors